These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1993259)

  • 1. Immunosuppressive and long-acting anti-inflammatory activity of mycophenolic acid and derivative, RS-61443.
    Allison AC; Eugui EM
    Br J Rheumatol; 1991; 30 Suppl 2():57-61. PubMed ID: 1993259
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive and other anti-rheumatic activities of mycophenolate mofetil.
    Allison AC; Eugui EM
    Agents Actions Suppl; 1993; 44():165-88. PubMed ID: 8372727
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.
    Allison AC; Almquist SJ; Muller CD; Eugui EM
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):10-4. PubMed ID: 2063415
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents.
    Eugui EM; Mirkovich A; Allison AC
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):15-8. PubMed ID: 2063416
    [No Abstract]   [Full Text] [Related]  

  • 5. RS-61443 studies: review and proposal.
    Platz KP; Eckhoff DE; Hullett DA; Sollinger HW
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):33-5. PubMed ID: 2063420
    [No Abstract]   [Full Text] [Related]  

  • 6. RS-61443: a new immunosuppressive agent.
    Young CJ; Sollinger HW
    Transplant Proc; 1994 Dec; 26(6):3144-6. PubMed ID: 7998096
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of RS-61443 on antibody-mediated rejection.
    Knechtle SJ; Wang J; Burlingham WJ; Beeskau M; Subramanian R; Sollinger HW
    Transplantation; 1992 Mar; 53(3):699-701. PubMed ID: 1549873
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of RS-61443 on pancreatic islet xenografts.
    Beger C; Vajkoczy P; Menger MD; Messmer K
    Transplant Proc; 1994 Apr; 26(2):759. PubMed ID: 8171650
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents.
    Hullett DA; Sollinger HW
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):45-7. PubMed ID: 8516943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.
    Morris RE; Wang J; Blum JR; Flavin T; Murphy MP; Almquist SJ; Chu N; Tam YL; Kaloostian M; Allison AC
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):19-25. PubMed ID: 2063417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunosuppressive agents--advances of the developmental studies and the mode of action].
    Ochiai T; Isono K; Gunji Y; Nagata M
    Nihon Rinsho; 1991 Jun; 49(6):1436-41. PubMed ID: 1715926
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785).
    Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
    Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
    Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
    [No Abstract]   [Full Text] [Related]  

  • 14. DAB486-IL-2 (IL-2-toxin) in combination with low-dose RS-61443 (mycophenolate mofetil) prolongs murine thyroid allograft survival.
    Hullett DA; Landry AS; Eckhoff DE; Nichols JC; Eugui EM; Allison AC; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):756-7. PubMed ID: 8438470
    [No Abstract]   [Full Text] [Related]  

  • 15. The chemistry of mycophenolic acid--synthesis and modifications towards desired biological activity.
    Cholewinski G; Malachowska-Ugarte M; Dzierzbicka K
    Curr Med Chem; 2010; 17(18):1926-41. PubMed ID: 20377512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor and immunosuppressive effects of mycophenolic acid derivatives.
    Ohsugi Y; Suzuki S; Takagaki Y
    Cancer Res; 1976 Aug; 36(8):2923-7. PubMed ID: 1277202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of both MLC and in vitro IgG memory response to tetanus toxoid by RS-61443.
    Burlingham WJ; Grailer AP; Hullett DA; Sollinger HW
    Transplantation; 1991 Feb; 51(2):545-7. PubMed ID: 1825249
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid.
    Vieregge B; Resch K; Kaever V
    Planta Med; 1999 Feb; 65(1):80-2. PubMed ID: 10083851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive and anti-inflammatory activities of sinomenine.
    Wang Q; Li XK
    Int Immunopharmacol; 2011 Mar; 11(3):373-6. PubMed ID: 21109035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid.
    Nelson PH; Eugui E; Wang CC; Allison AC
    J Med Chem; 1990 Feb; 33(2):833-8. PubMed ID: 1967654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.